Thomas Cusack
Board Member
Heron Therapeutics, Inc. /De/ (HRTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Thomas Cusack
Thomas Cusack is recorded as Board Member at Heron Therapeutics, Inc. /De/ (HRTX). Heron Therapeutics, Inc. /De/ reported in an 8-K filed October 29, 2025 that Thomas Cusack was appointed director, effective October 27, 2025.
“On October 27, 2025, the Board of Directors (the “Board”) of Heron Therapeutics, Inc. (the “Company”) appointed Thomas Cusack to the Board to serve for a term expiring at the Company’s 2026 Annual Meeting of Stockholders and until his successor is duly elected and qualified or until his earlier death, resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-10-27–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Heron Therapeutics, Inc. /De/
Other people whose current roles at this company are on record from its filings.
- Craig Collard CEO, Board Member
- Adam Morgan Chairman, Board Member
- Ira Duarte CFO, Chief Accounting Officer
- Mark Hensley COO
- Lisa Peraza Chief Accounting Officer
- Christian Waage Board Member
- Craig Johnson Board Member
- Kevin Kotler Board Member
- Michael Kaseta Board Member
- Sharmila Dissanaike Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.